Peter Langguth

In vivo Models and Decision Trees for Formulation Development in Early Drug Development: A Review of Current Practices and Recommendations for Biopharmaceutical Development.

P Zane, P Langguth, A Müllertz, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Mechanistic basis for unexpected bioavailability enhancement of polyelectrolyte complexes incorporating BCS class III drugs and carrageenans.

S. Reuss, P. Langguth, C. Heinen, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Investigation of charge ratio variation in mRNA - DEAE-dextran polyplex delivery systems.

D. Svergun, U. Şahin, C. Blanchet, 2019, Biomaterials.

Mechanistic analysis and experimental verification of bicarbonate‐controlled enteric coat dissolution: Potential in vivo implications

G. Amidon, M. Bermejo, G. Amidon, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Toward Biopredictive Dissolution for Enteric Coated Dosage Forms.

G. Amidon, P. Langguth, J. Al-Gousous, 2016, Molecular pharmaceutics.

Nanosuspension Formulations for Low-Soluble Drugs: Pharmacokinetic Evaluation Using Spironolactone as Model Compound

G Vergnault, P Langguth, P. Langguth, 2005, Drug development and industrial pharmacy.

The effects of three absorption‐modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs

H. Lennernäs, P. Langguth, E. Sjögren, 2018, International journal of pharmaceutics.

Cinnamate uptake by rat small intestine: transport kinetics and transepithelial transfer

S. Wolffram, P. Ader, P. Langguth, 1996, Experimental physiology.